News & Updates

Treatment with semaglutide with firsocostat and/or cilofexor is well tolerated in patients with mild-to-moderate fibrosis due to nonalcoholic steatohepatitis (NASH), a study has shown.

Recipients of liver transplantation fare well with the use of statins, which a recent study showing that the drugs confer survival advantage.

The benefit of adding durvalumab to gemcitabine plus cisplatin chemotherapy in patients with advanced biliary tract cancer (BTC) was consistent regardless of primary tumour location, according to a subgroup analysis of the phase III TOPAZ-1 study presented at ESMO GI 2022.

A history of abnormalities found during ultrasonography appears to aggravate the diagnosis of cholangiocarcinoma, particularly among those with dilated bile ducts and liver mass, reports a recent Thailand study.

Bulevirtide at a dose of 2 mg or 10 mg daily induces biochemical and virological response in patients with chronic hepatitis D virus (HDV) infection, according to results of Study MYR301.